Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Carboplatin, Paclitaxel and Cetuximab for Recurrent or Metastatic SCCHN
NCT02124707Phase 2Completed
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Jun 2014
- Primary completion
- Oct 2019
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140, Paclitaxel Micelles for Injection, carboplatin in squamous cell carcinoma of the head and neck (HNSCC), sponsored by UNC Lineberger Comprehensive Cancer Center. Started Jun 2014; status: completed.
02
Drugs
KL-140Paclitaxel Micelles for Injectioncarboplatin
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT02124707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02124707.